OSE Pharma (France) Today
| OSE Stock | EUR 8.68 0.03 0.35% |
Performance7 of 100
| Odds Of DistressLess than 33
|
OSE Pharma is trading at 8.68 as of the 21st of November 2024, a 0.35% up since the beginning of the trading day. The stock's open price was 8.65. OSE Pharma has about a 33 percent probability of financial distress in the next few years of operation and did not have a very good performance during the last 90 trading days. Equity ratings for OSE Pharma SA are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 22nd of October 2024 and ending today, the 21st of November 2024. Click here to learn more.
OSE Immunotherapeutics SA, a biotechnology company, focuses on the development of immunotherapies for immune activation and regulation in the fields of immuno-oncology and autoimmune diseases. OSE Immunotherapeutics SA is headquartered in Nantes, France. The company has 18.44 M outstanding shares. More on OSE Pharma SA
Moving together with OSE Stock
Moving against OSE Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
OSE Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. OSE Pharma's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding OSE Pharma or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) |
OSE Pharma SA (OSE) is traded on Euronext Paris in France and employs 60 people. The company currently falls under 'Small-Cap' category with a current market capitalization of 104.49 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate OSE Pharma's market, we take the total number of its shares issued and multiply it by OSE Pharma's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. OSE Pharma SA operates under Biotechnology sector and is part of Health Care industry. The entity has 18.44 M outstanding shares.
OSE Pharma SA has accumulated about 33.58 M in cash with (9.92 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.84.
Check OSE Pharma Probability Of Bankruptcy
Ownership AllocationOSE Pharma owns a total of 18.44 Million outstanding shares. OSE Pharma has noticeable amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check OSE Ownership Details
OSE Pharma SA Risk Profiles
Although OSE Pharma's alpha and beta are two of the key measurements used to evaluate OSE Pharma's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 3.16 | |||
| Semi Deviation | 3.95 | |||
| Standard Deviation | 4.24 | |||
| Variance | 17.98 |
OSE Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in OSE Pharma without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run USA ETFs Now
USA ETFsFind actively traded Exchange Traded Funds (ETF) in USA |
| All Next | Launch Module |
OSE Pharma Corporate Management
Elected by the shareholders, the OSE Pharma's board of directors comprises two types of representatives: OSE Pharma inside directors who are chosen from within the company, and outside directors, selected externally and held independent of OSE. The board's role is to monitor OSE Pharma's management team and ensure that shareholders' interests are well served. OSE Pharma's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, OSE Pharma's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Brangre Vasseur | Chief ImmunoOncology | Profile | |
| Alain MD | Medical Director | Profile | |
| Silvia MD | Head Devel | Profile | |
| AnneLaure AutretCornet | Chief Financial and Administrative Officer | Profile | |
| JeanPascal PharmD | Chief Person | Profile | |
| Dominique MD | Chairman Founder | Profile |
Other Information on Investing in OSE Stock
OSE Pharma financial ratios help investors to determine whether OSE Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in OSE with respect to the benefits of owning OSE Pharma security.